NICE has endorsed idebenone (Raxone) on the NHS to treat Leber’s hereditary optic neuropathy in individuals aged 12 and over, offering hope to around 250 people.
Professor Adrian Wilson, MBBS, BSc (Hons), FRCS, FRCS Tr & Orth Specialist Knee Surgeon (Professor), tells us what we need to know about exciting new regenerative treatments that take centre stage for knees in the world of orthobiologics.
Gregory H Hipskind MD PhD and Jody L Mittiga DNM NP from Brain Injury Consulting LLC, reveal their thoughts on evaluating and treating mild traumatic brain injury (mTBI), including the role of SPECT and photobiomodulation therapy.
For a long time the causes of acute coronary syndromes were poorly understood, and, only after the publication of our paper on New England Journal of Medicine on the importance of inflammation it was recognised as a crucial pathogenetic mechanism.
Ahead of World Pancreatic Cancer Day, Professor Matthias Löhr, a member of the UEG Public Affairs Committee, explains why we must increase pancreatic cancer awareness.
The Keep Antibiotics Working campaign is back to alert the public to the risks of antibiotic resistance, urging people to always take their doctor, pharmacist or nurse’s advice.
Regina Fluhrer from the University of Augsburg and Bernd Schröder from the TU in Dresden discuss the potential of intramembrane proteases as targets for cancer therapies.
The NHS reports that 1 in 5 women in the UK are currently affected by PCOS, but what do we really know about the condition? It’s imperative that women have a clear understanding of their reproductive health. here, we explain everything you need to know about PCOS.
Dr Gerry Morrow shares his thoughts on the precision medicine, defined as the cost-effectiveness of breakthrough treatments and explains why this area is a priority for both researchers and government.
Patients will benefit from significant government investment in new NHS technology to improve treatment, diagnosis and care options for diseases including cancer.
